PRDM13 Antikörper (N-Term)
-
- Target Alle PRDM13 Antikörper anzeigen
- PRDM13 (PR Domain Containing 13 (PRDM13))
-
Bindungsspezifität
- N-Term
-
Reaktivität
- Human, Hund
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser PRDM13 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Kreuzreaktivität
- Hund
- Aufreinigung
- Purified
- Immunogen
- PRDM13 antibody was raised in rabbit using the N terminal of PRDM13 as the immunogen
- Top Product
- Discover our top product PRDM13 Primärantikörper
-
-
- Applikationshinweise
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. - Kommentare
-
PRDM13 Blocking Peptide, catalog no. 33R-3733, is also available for use as a blocking control in assays to test for specificity of this PRDM13 antibody
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Konzentration
- Lot specific
- Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
- Handhabung
- Avoid repeated freeze/thaw cycles.
- Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
- Target
- PRDM13 (PR Domain Containing 13 (PRDM13))
- Andere Bezeichnung
- PRDM13 (PRDM13 Produkte)
- Synonyme
- MU-MB-20.220 antikoerper, PFM10 antikoerper, PR/SET domain 13 antikoerper, PR domain containing 13 antikoerper, PRDM13 antikoerper, prdm13 antikoerper, Prdm13 antikoerper
- Hintergrund
- PRDM13 may be involved in transcriptional regulation. Synonyms: Polyclonal PRDM13 antibody, Anti-PRDM13 antibody, PR domain containing 13 antibody, MU-MB-20.220 antibody, PFM10 antibody.
-